Ronsbotic Pharma India Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 13-12-2024
- Paid Up Capital ₹ 0.50 M
as on 13-12-2024
- Company Age 2 Year, 30 Days
- Last Filing with ROC 31 Mar 2024
About Ronsbotic Pharma India
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Nirmala Agrawal, Rajesh Agrawal, Omprakash Mundhada, and One other member serve as directors at the Company.
- CIN/LLPIN
U33100MH2022PTC393993
- Company No.
393993
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Nov 2022
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Amravati, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Ronsbotic Pharma India?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nirmala Agrawal  | Director | 23-Nov-2022 | Current |
| Rajesh Agrawal | Director | 23-Nov-2022 | Current |
| Omprakash Mundhada | Director | 23-Nov-2022 | Current |
| Shubhangi Mundhada | Director | 23-Nov-2022 | Current |
Financial Performance of Ronsbotic Pharma India.
Enhance accessibility to Ronsbotic Pharma India's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Ronsbotic Pharma India?
Unlock access to Ronsbotic Pharma India's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Tolu Tours Private LimitedActive 23 years 7 monthsNirmala Agrawal and Rajesh Agrawal are mutual person
Zenmer Technologies Private LimitedActive 11 years 8 monthsNirmala Agrawal and Rajesh Agrawal are mutual person
Chudiwal Agro & Food Industry Private LimitedActive 4 years 5 monthsNirmala Agrawal is a mutual person
- Nirantar Healthcare Private LimitedActive 1 year 11 days
Omprakash Mundhada and Shubhangi Mundhada are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Ronsbotic Pharma India?
Ronsbotic Pharma India has a workforce of 0 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ronsbotic Pharma India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ronsbotic Pharma India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
